MedTrace Logo

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine

NCT03287830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2105

Last updated 2023-09-15

Study results available
· View outcomes & findings →

Summary

This multi-site study assesses the impact of text message reminders on the receipt of the second dose of influenza vaccine, and takes place primarily in practices from the American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) network.

Conditions

Interventions

BEHAVIORAL

Text message influenza vaccine reminders

Text message reminders for second dose of influenza vaccination

Sponsors & Collaborators

Principal Investigators

  • Melissa Stockwell, MD, MPH · Columbia University

  • Alex Fiks, MD, MSCE · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-06
Primary Completion
2019-04-30
Completion
2019-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03287830 on ClinicalTrials.gov